These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17283084)

  • 1. The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice.
    Charles E; Callegan MC; Blader IJ
    Infect Immun; 2007 Apr; 75(4):2079-83. PubMed ID: 17283084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
    Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
    Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-regulated Toxoplasma gondii distribution and load in the murine eye.
    Norose K; Mun HS; Aosai F; Chen M; Piao LX; Kobayashi M; Iwakura Y; Yano A
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4375-81. PubMed ID: 14507882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
    Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
    Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii.
    Rachinel N; Buzoni-Gatel D; Dutta C; Mennechet FJ; Luangsay S; Minns LA; Grigg ME; Tomavo S; Boothroyd JC; Kasper LH
    J Immunol; 2004 Aug; 173(4):2725-35. PubMed ID: 15294991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
    Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
    Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii strain-specific transcript levels of SAG1 and their association with virulence.
    Windeck T; Gross U
    Parasitol Res; 1996; 82(8):715-9. PubMed ID: 8897506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection.
    Cunha-Júnior JP; Silva DA; Silva NM; Souza MA; Souza GR; Prudencio CR; Pirovani CP; Cezar M Cascardo J; Barbosa BF; Goulart LR; Mineo JR
    Immunobiology; 2010; 215(1):26-37. PubMed ID: 19261354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IL-27/IL-27R expression in association with the immunopathology of murine ocular toxoplasmosis.
    Tong X; Chen S; Zheng H; Huang S; Lu F
    Parasitol Res; 2018 Jul; 117(7):2255-2263. PubMed ID: 29779048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
    Liu Q; Gao S; Jiang L; Shang L; Men J; Wang Z; Zhai Y; Xia Z; Hu R; Zhang X; Zhu XQ
    Microbes Infect; 2008 Oct; 10(12-13):1355-62. PubMed ID: 18761418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of a recombinant colorimetric SAG1-alkaline phosphatase conjugate to detect specific antibody responses against Toxoplasma gondii.
    Chahed Bel-Ochi N; Bouratbine A; Mousli M
    J Immunol Methods; 2013 Aug; 394(1-2):107-14. PubMed ID: 23727049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii: stable complementation of sag1 (p30) mutants using SAG1 transfection and fluorescence-activated cell sorting.
    Kim K; Boothroyd JC
    Exp Parasitol; 1995 Feb; 80(1):46-53. PubMed ID: 7821410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
    Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
    Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
    Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
    J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.